More than a decade ago, mPOC technologies (rapid, portable PCR and other NAAT-based tests) came on the scene. Their reputation was already being proven in anti-microbial stewardship and in the detection of common infectious disease threats. The COVID-19 pandemic sealed their presence in the healthcare system.
Now the questions can be asked: Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Molecular Diagnostics at the Point of Care. In 489 pages, the report contains the following:
- Expert Market Situational Analysis
- Company Assessments
- Recent Trends in the Industry
- Molecular Point of Care Markets by Country
- Molecular Point of Care Markets by Technology
- Molecular Point of Care – Respiratory
- Molecular Point of Care – Gastrointestinal
- Molecular Point of Care – STI
- Molecular Point of Care – Other Markets
- Physician and Laboratory Customer Statistics
- Fee Schedules and Most Used Tests
- The Future of Molecular Point of Care
Point of Care testing is proving itself in the market. Players are reporting surprising growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. It could possibly displace most frontline test protocols AND save money at the same time. The report forecasts the market size out for five years.
Reviews
There are no reviews yet.